Related Experiment Video
Updated: Sep 27, 2025

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
Published on: April 21, 2022
Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis
Bobeck S Modjtahedi1,2,3, Duy Do1, Tiffany Q Luong1
1Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena.
Insights
COVID-19 infection was associated with a higher incidence of retinal vein occlusions (RVOs), though these events remain rare. Further research is needed to establish a definitive link between COVID-19 and retinal vascular events.
Area of Science:
- Ophthalmology
- Vascular Biology
- Infectious Diseases
Background:
- COVID-19 (coronavirus disease 2019) is known to cause systemic vascular damage.
- The specific impact of COVID-19 on retinal vasculature and the risk of retinal vascular occlusions (RVOs) are not fully understood.
Purpose of the Study:
- To investigate the incidence of retinal vascular occlusions following COVID-19 infection.
- To determine if COVID-19 diagnosis is associated with an increased risk of retinal artery occlusions (RAOs) and retinal vein occlusions (RVOs).
Main Methods:
- A cohort study was conducted using data from Kaiser Permanente Southern California.
- Patients diagnosed with COVID-19 between January 2020 and May 2021 without a prior history of RVOs or RAOs were included.
- The incidence of new RAOs and RVOs in the six months post-COVID-19 diagnosis was compared to the six months prior, with adjustments for demographic and clinical factors.
Main Results:
- The study included over 432,000 patients with COVID-19.
- A statistically significant increase in the incidence of RVOs was observed in the six months after COVID-19 infection (adjusted IRR, 1.54; P=.03).
- A smaller, non-significant increase in RAO incidence was noted post-COVID-19 (adjusted IRR, 1.35; P=.44). Peak incidence for RVOs and RAOs occurred 6-8 and 10-12 weeks post-diagnosis, respectively.
Conclusions:
- The findings suggest an elevated incidence of RVOs following COVID-19 infection, although these events are infrequent.
- A causal relationship cannot be definitively established due to the observational nature of the study.
- Further large-scale epidemiological studies are recommended to clarify the association between COVID-19 and retinal thromboembolic events.
Importance:
COVID-19 is associated with systemic vascular damage; however, the risk posed to the retinal vasculature remains incompletely understood.
Objective:
To assess if there is a change in the incidence of retinal vascular occlusions after COVID-19 infection.
Design, Setting, And Participants:
This cohort study at an integrated health care organization (Kaiser Permanente Southern California) included patients without a history of retinal vascular occlusion who were diagnosed with COVID-19 infection between January 20, 2020, and May 31, 2021. Patients were excluded if they had a history of retinal artery occlusions (RAOs) or retinal vein occlusions (RVOs) more than 6 months before their COVID-19 diagnosis or if they were enrolled in Kaiser Permanente Southern California for less than 6 months before COVID-19 diagnosis.
Exposures:
COVID-19 infection.
Main Outcomes And Measures:
The change in the average biweekly incidence of new RAOs and RVOs after COVID-19 diagnosis. Adjusted incidence rate ratios (IRRs) were calculated to compare the incidence of retinal vascular occlusions before and after COVID-19 diagnosis after accounting for baseline demographic characteristics, medical history, and hospitalization.
Results:
A total of 432 515 patients diagnosed with COVID-19 infection were included in this study. The mean (SD) age was 40.9 (19.2) years, and 231 767 patients (53.6%) were women. Sixteen patients had an RAO (crude incidence rate, 3.00 per 1 000 000 patients), and 65 had an RVO (crude incidence rate, 12.20 per 1 000 000 patients) in the 6 months after COVID-19 diagnosis. The incidence of new RVOs was higher in the 6 months after COVID-19 infection compared with the 6 months before infection after adjusting for age; sex; self-reported race and ethnicity; body mass index; history of diabetes, hypertension, or hyperlipidemia; and hospitalization (adjusted IRR, 1.54; 95% CI, 1.05-2.26; P = .03). There was a smaller increase in the incidence of RAOs after COVID-19 diagnosis (IRR, 1.35; 95% CI, 0.64-2.85; P = .44). The peak incidence of RAOs and RVOs occurred 10 to 12 weeks and 6 to 8 weeks after COVID-19 diagnosis, respectively.
Conclusions And Relevance:
The findings of this study suggest that there was an increase in the incidence of RVOs after COVID-19 infection; however, these events remain rare, and in the absence of randomized controls, a cause-and-effect relationship cannot be established. Further large, epidemiologic studies are warranted to better define the association between retinal thromboembolic events and COVID-19 infection.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways

